<?xml version="1.0" encoding="UTF-8"?>
<EmailTemplate xmlns="http://soap.sforce.com/2006/04/metadata">
    <available>true</available>
    <encodingKey>ISO-8859-1</encodingKey>
    <letterhead>DRE_Logo</letterhead>
    <name>DRE-GROWTH-ICER-replication</name>
    <style>freeForm</style>
    <subject>Sign up for open access to ICER MM Review Replication</subject>
    <textOnly>The first review tested by GROWTH Replicator is a recently released review conducted by the
Institute for Clinical and Economic Review (ICER)
on Multiple Myeloma.

Scientists can enroll to use DRE&apos;s platform, a protected login site,where they can view the underlying data used in this particular review.
GROWTH REPLICATOR
ICER Multiple Myeloma Forum

Doctor Evidence launched GROWTH Replicator, a site that enables stakeholders across the healthcare ecosystem free access to a platform to replicate systematic evidence reviews. Doctor Evidence (DRE) is a leading human-enabled technology platform company that provides solutions for dynamic identification, synthesis, and analysis to perform evidence-based medicine evaluations. The GROWTH Replicator site will enable users to utilize DREâ€™s platform and Digital Outcome Conversion (DOC) technology to reproduce reviews, as well as provide an open access interface for the stated data and methods of a review.
Through GROWTH Replicator, Doctor Evidence is providing an ecosystem where scientists and methodologists can communicate in an open forum by testing, iterating, investigating, and replicating an evidence review.
Read press release.</textOnly>
    <type>html</type>
    <uiType>Aloha</uiType>
</EmailTemplate>
